Emany Sravan Kumar 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Emany Sravan Kumar
SVP, Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2024-11-18$4.08/sh−11,001$44,884→ 309,572 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.